MedaSorb Announces IDE Filing With the FDA MONMOUTH JUNCTION, N.J., Jan. 4, 2007 (PRIME NEWSWIRE) -- MedaSorb Technologies Corporation (OTCBB:MSBT) today announced that is has submitted an Investigational Device Exemption (IDE) Supplement to...

MedaSorb Names Former Bristol Meyers Vice Chairman, William R. Miller, as Chairman of the Board MONMOUTH JUNCTION, N.J., Dec. 19, 2006 (PRIME NEWSWIRE) -- MedaSorb Technologies Corporation (OTCBB:MSBT) announced today the appointment of William R. Miller as Chairman of the Board of Directors,...

MedaSorb Technologies Corporation Files New Patent Application MONMOUTH JUNCTION, N.J., Nov. 13, 2006 (PRIMEZONE) -- MedaSorb Technologies Corporation (OTCBB:MSBT) announced today that it has filed a new patent application covering its Ultra Select(tm) polymer...

MedaSorb Technologies Adds Strategic Technology Patent MONMOUTH JUNCTION, N.J., Oct. 27, 2006 (PRIMEZONE) -- MedaSorb Technologies (OTCBB:MSBT) announced today that it has acquired ownership of Patent No. 6,884,829 from Robert Albright, Ph.D., a...

MedaSorb Announces That They Intend to File Investigational Device Exemption With the FDA MONMOUTH JUNCTION, N.J., Sept. 19, 2006 (PRIMEZONE) -- MedaSorb Technologies, Inc. (OTCBB:MSBT) announced today that they intend to file an Investigational Device Exemption (IDE) with the FDA by the...